|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Á¦¾à Biologics ¹ÙÀÌ¿ÀÀǾàÇ° Ç°Áúº¸Áõ/
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
¹ÙÀÌ¿ÀÀǾàÇ° ¹è¾ç Á¤Á¦ °øÁ¤±â¼ú »ý»ê
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Biologics ¹ÙÀÌ¿ÀÀǾàÇ° Ç°Áúº¸Áõ/QA -
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Drug Safety / PV Pharmacovigilance °æ
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Á¦¾à BD/Á¦¾à°³¹ß/¶óÀ̼¾½ºÀÎ - ´ë±â¾÷
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Á¦¾à ¹ÙÀÌ¿ÀÀǾàÇ° Ç°Áú°ü¸®ÆÀÀå - ´ë±â
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)¿¡ÀÌÄ¡¾Ë±×·ì |
ÀǾàÇ°ÇØ¿Ü BD, AllianceManagement,ÇØ
¼¿ï ÀüÁö¿ª, ¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)¿¡ÀÌÄ¡¾Ë±×·ì |
(ºÎÀå-ÀÌ»ç±ÞÀÌ»ó)Á¦¾àÀǾàÇÕ¼º ºÐ¾ß ÆÀ
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¹Ú»ç) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Á¦¾à ¹ÙÀÌ¿À ¹°·ù/SCM °æ·Â - ´ë±â¾÷ Á¦
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Á¦¾à ¿ø·áÀǾàÇ° Ç°Áúº¸ÁõÆÀÀå - ÄÚ½º´Ú
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)º£½ºÆ®¿¡Ä¡¾Ë (Best HR) |
Á¦¾à BD/»ç¾÷°³¹ß/¸¶ÄÉÆà - ´ë±â¾÷ Á¦¾à
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)±ÝºûÁö¿£¾¾ |
½ÄÇ° ´Ü¼ø »ý»êÁ÷ º¸Á¶ ¹× Ãâ°í´ã´ç ±¸
°æ±â ±¤Áֽà | Çз¹«°ü |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)¿¡ÀÌÄ¡¾Ë±×·ì |
Á¦¾àÀǾàÇÕ¼º ºÐ¾ß ÆÀÀå(ºÎÀå-ÀÌ»ç±ÞÀÌ
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¹Ú»ç) Á¹¾÷ |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)ÆʽºÅ丮 Çѳà |
»ç¹«°ü¸®Á÷, ¿µ¾÷Á÷, »ý»êÁ÷ ÀηÂÃæ¿ø
ÃæºÏ ÀüÁö¿ª | Çз¹«°ü |
|
°æ·Â¹«°ü |
|
04.04 |
|
|
(ÁÖ)¾Ç¸¶ÀÇ Àë |
2018³â »ó¹Ý±â ½ÄÇ°°¡°ø¡¤°³¹ß °æ·Â¹«°ü
¼¿ï ¿µµîÆ÷±¸ | Çз¹«°ü |
|
°æ·Â¹«°ü |
|
04.04 |
|